KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,988,322 | -22.3% | 35,415 | -0.4% | 0.02% | -19.2% |
| Q2 2023 | $7,707,066 | +127.8% | 35,541 | +90.8% | 0.03% | +116.7% |
| Q1 2023 | $3,383,590 | -58.2% | 18,628 | -54.7% | 0.01% | -58.6% |
| Q4 2022 | $8,088,923 | -56.6% | 41,165 | -50.3% | 0.03% | -21.6% |
| Q3 2022 | $18,618,178 | +54.2% | 82,774 | -13.3% | 0.04% | +68.2% |
| Q2 2022 | $12,076,449 | -2.1% | 95,462 | -1.9% | 0.02% | +22.2% |
| Q1 2022 | $12,339,601 | +26.5% | 97,320 | +30.7% | 0.02% | -28.0% |
| Q4 2021 | $9,756,000 | +8.4% | 74,471 | +1.2% | 0.02% | 0.0% |
| Q3 2021 | $9,001,000 | -44.3% | 73,582 | -48.1% | 0.02% | +8.7% |
| Q2 2021 | $16,158,000 | +89.4% | 141,746 | +99.7% | 0.02% | -11.5% |
| Q1 2021 | $8,533,000 | +59.0% | 70,975 | +34.4% | 0.03% | +52.9% |
| Q4 2020 | $5,365,000 | +36.9% | 52,809 | +4.2% | 0.02% | +21.4% |
| Q3 2020 | $3,919,000 | -65.6% | 50,683 | -50.4% | 0.01% | -36.4% |
| Q2 2020 | $11,380,000 | – | 102,092 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |